Other Income & Expense
Other Charges
Pfizer Other Charges increased by 80.9% to -$861.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.7%, from -$953.00M to -$861.00M. Over 3 years (FY 2021 to FY 2025), Other Charges shows a downward trend with a 11.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionOther Income & Expense
CategoryRisk
SignalLower is better
VolatilityVolatile
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase suggests unexpected non-operating costs or one-time financial hits, which can negatively impact net income.
Detailed definition
This metric captures non-operating financial expenses that do not fall under standard categories like interest or taxes....
Peer comparison
Often found in the non-operating section of the income statement; peers may label these as 'other expenses' or 'sundry charges'.
Metric ID:
hon_other_chargesHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.34B | $1.70B | $835.00M | -$350.00M | -$772.00M | $59.00M | $0.00 | -$275.00M | $75.00M | -$181.00M | -$680.00M | -$1.11B | -$243.00M | -$2.36B | -$953.00M | -$739.00M | -$517.00M | -$4.51B | -$861.00M |
| QoQ Change | — | +26.3% | -50.8% | -141.9% | -120.6% | +107.6% | -100.0% | — | +127.3% | -341.3% | -275.7% | -62.8% | +78.0% | -870.4% | +59.6% | +22.5% | +30.0% | -773.1% | +80.9% |
| YoY Change | — | — | — | — | -157.5% | -96.5% | -100.0% | +21.4% | +109.7% | -406.8% | -147.3% | <-999% | -34.3% | — | -40.1% | +33.2% | -112.8% | -91.4% | +9.7% |
Range-$4.51B – $1.70B
CAGR-9.4%
Avg YoY Growth-184.9%
Median YoY Growth-94.0%
Business Segments
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Biopharma | $90.00M | $128.00M | $51.00M | $78.00M | $115.00M | $120.00M | $268.00M | $116.00M |
| Total | -$1.11B | -$243.00M | -$2.36B | -$953.00M | -$739.00M | -$517.00M | -$4.51B | -$861.00M |
Other Charges at Other Companies
Frequently Asked Questions
- What is Pfizer's other charges?
- Pfizer (PFE) reported other charges of -$861.00M in Q1 2026.
- How has Pfizer's other charges changed year-over-year?
- Pfizer's other charges increased by 9.7% year-over-year, from -$953.00M to -$861.00M.
- What is the long-term trend for Pfizer's other charges?
- Over 3 years (2021 to 2025), Pfizer's other charges has grown at a 11.3% compound annual growth rate (CAGR), from $4.88B to -$6.72B.
- What does other charges mean?
- Miscellaneous non-operating financial expenses not classified elsewhere.